Phreesia Inc (PHR)
18.60
+0.14
(+0.76%)
USD |
NYSE |
Nov 05, 16:00
18.60
0.00 (0.00%)
After-Hours: 20:00
Phreesia Revenue (Quarterly): 102.12M for July 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | 102.12M |
April 30, 2024 | 101.22M |
January 31, 2024 | 95.00M |
October 31, 2023 | 91.62M |
July 31, 2023 | 85.83M |
April 30, 2023 | 83.84M |
January 31, 2023 | 76.59M |
October 31, 2022 | 73.10M |
July 31, 2022 | 67.87M |
April 30, 2022 | 63.35M |
January 31, 2022 | 58.02M |
October 31, 2021 | 55.92M |
July 31, 2021 | 51.01M |
Date | Value |
---|---|
April 30, 2021 | 48.29M |
January 31, 2021 | 41.81M |
October 31, 2020 | 38.46M |
July 31, 2020 | 35.01M |
April 30, 2020 | 33.40M |
January 31, 2020 | 32.82M |
October 31, 2019 | 32.84M |
July 31, 2019 | 30.82M |
April 30, 2019 | 28.31M |
January 31, 2019 | 26.48M |
October 31, 2018 | 24.76M |
July 31, 2018 | 24.78M |
April 30, 2018 | 23.87M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
32.82M
Minimum
Jan 2020
102.12M
Maximum
Jul 2024
65.01M
Average
63.35M
Median
Apr 2022
Revenue (Quarterly) Benchmarks
American Shared Hospital Services | 7.056M |
Novo Integrated Sciences Inc | 3.152M |
Astrana Health Inc | 486.26M |
Cryo-Cell International Inc | 8.067M |
P3 Health Partners Inc | 379.16M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -18.01M |
Total Expenses (Quarterly) | 119.34M |
EPS Diluted (Quarterly) | -0.31 |
Enterprise Value | 984.70M |
Gross Profit Margin (Quarterly) | 67.87% |
Profit Margin (Quarterly) | -17.64% |
Earnings Yield | -9.68% |
Normalized Earnings Yield | -9.677 |